NCT01708837

Brief Summary

The purpose of this study is to investigate whether the depth of anesthesia with propofol affects the incidence of early postoperative cognitive dysfunction

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

October 7, 2012

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 17, 2012

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

May 31, 2013

Status Verified

October 1, 2012

Enrollment Period

1.3 years

First QC Date

October 7, 2012

Last Update Submit

May 29, 2013

Conditions

Keywords

Postoperative Cognitive DysfunctionBispectral index

Outcome Measures

Primary Outcomes (1)

  • cognitive function score measured by Wechsler memory scale/ Wechsler intelligence scale manual

    cognitive function test using Wechsler memory scale/ Wechsler intelligence scale manual were administered the day before and 7 days and 3 months after surgery.

    Three month

Study Arms (2)

deep anesthesia group

OTHER

Propofol infusion rate is titrated to maintain the target BIS values in 30-45

Drug: Propofol

light anesthesia group

OTHER

Propofol infusion rate is titrated to maintain the target BIS values in 45-60

Drug: Propofol

Interventions

Propofol infusion rate is titrated to maintain the target BIS values

deep anesthesia grouplight anesthesia group

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent provided by legal guardians or patients
  • Male or female patients between 50 and 70 years of age.
  • ASA physical status I or II patients.
  • Education Years of patients are more than 6 years.
  • The operation going to be received is the first operation in patient's life (a second operation was a risk factor for early post- operative cognitive dysfunction);
  • The operation going to be received is presenting for a moderate surgery, such as pulmonary lobectomy, subtotal gastrectomy, prostatectomy and so on.

You may not qualify if:

  • The patient has the history of neurologic or mental disease.
  • The patient has renal dysfunction, serum creatinine \>177 mmol/L.
  • The patient has an active liver disease.
  • The patient has cardiac dysfunction.
  • The patient has pulmonary dysfunction.
  • The patient has an endocrine disease.
  • The patient has a metabolic disease.
  • The patient has a history of surgery.
  • The patient is going to receive surgery of thyroid, intracranial procedure, joint replacement, major fracture.
  • The patient's education history is shown less than 6 years of school.
  • The patient is unable to complete neuropsychologic testing.
  • The patient has vision dysfunction.
  • The patient has auditory dysfunction.
  • The operation going to be received is a laparoscopic surgery.
  • The patient is hypersensitive to propofol or any other anesthetic agents.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

XiangYa Hospital, Central South University

Changsha, Hunan, 410078, China

Location

Related Publications (13)

  • Newman S, Stygall.J: Neuropsychological outcome following cardiac surgery. The Brain and cardiac Surgery 2000: 21-49

    BACKGROUND
  • Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, Langeron O, Johnson T, Lauven PM, Kristensen PA, Biedler A, van Beem H, Fraidakis O, Silverstein JH, Beneken JE, Gravenstein JS. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet. 1998 Mar 21;351(9106):857-61. doi: 10.1016/s0140-6736(97)07382-0.

    PMID: 9525362BACKGROUND
  • Rasmussen LS, Christiansen M, Rasmussen H, Kristensen PA, Moller JT. Do blood concentrations of neurone specific enolase and S-100 beta protein reflect cognitive dysfunction after abdominal surgery?ISPOCD Group. Br J Anaesth. 2000 Feb;84(2):242-4. doi: 10.1093/oxfordjournals.bja.a013410.

    PMID: 10743460BACKGROUND
  • Canet J, Raeder J, Rasmussen LS, Enlund M, Kuipers HM, Hanning CD, Jolles J, Korttila K, Siersma VD, Dodds C, Abildstrom H, Sneyd JR, Vila P, Johnson T, Munoz Corsini L, Silverstein JH, Nielsen IK, Moller JT; ISPOCD2 investigators. Cognitive dysfunction after minor surgery in the elderly. Acta Anaesthesiol Scand. 2003 Nov;47(10):1204-10. doi: 10.1046/j.1399-6576.2003.00238.x.

    PMID: 14616316BACKGROUND
  • Johnson T, Monk T, Rasmussen LS, Abildstrom H, Houx P, Korttila K, Kuipers HM, Hanning CD, Siersma VD, Kristensen D, Canet J, Ibanaz MT, Moller JT; ISPOCD2 Investigators. Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology. 2002 Jun;96(6):1351-7. doi: 10.1097/00000542-200206000-00014.

    PMID: 12170047BACKGROUND
  • Cai YR, Xue ZG, Zhu B: Risk factors contributing to post- operative cognitive dysfunction in elderly patients. The Journal of Clinical Anesthesiology 2006; 22: 608-610

    BACKGROUND
  • Enlund M, Mentell O, Flenninger A, Horneman G, Ronquist G. Evidence of cerebral dysfunction associated with isoflurane- or propofol based anaesthesia for orthognathic surgery, as assessed by biochemical and neuropsychological methods. Ups J Med Sci. 1998;103(1):43-59. doi: 10.3109/03009739809178944.

    PMID: 9789971BACKGROUND
  • Casati A, Fanelli G, Pietropaoli P, Proietti R, Tufano R, Danelli G, Fierro G, De Cosmo G, Servillo G; Collaborative Italian Study Group on Anesthesia in Elderly Patients. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg. 2005 Sep;101(3):740-747. doi: 10.1213/01.ane.0000166974.96219.cd.

    PMID: 16115985BACKGROUND
  • Shim TS, Lee JH, Kim SY, Lim TH, Kim SJ, Kim DS, Kim WD. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest. 2001 Nov;120(5):1506-13. doi: 10.1378/chest.120.5.1506.

    PMID: 11713127BACKGROUND
  • Farag E, Chelune GJ, Schubert A, Mascha EJ. Is depth of anesthesia, as assessed by the Bispectral Index, related to postoperative cognitive dysfunction and recovery? Anesth Analg. 2006 Sep;103(3):633-40. doi: 10.1213/01.ane.0000228870.48028.b5.

    PMID: 16931673BACKGROUND
  • Newman S, Stygall J, Hirani S, Shaefi S, Maze M. Postoperative cognitive dysfunction after noncardiac surgery: a systematic review. Anesthesiology. 2007 Mar;106(3):572-90. doi: 10.1097/00000542-200703000-00023.

  • Abildstrom H, Rasmussen LS, Rentowl P, Hanning CD, Rasmussen H, Kristensen PA, Moller JT. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand. 2000 Nov;44(10):1246-51. doi: 10.1034/j.1399-6576.2000.441010.x.

  • Ni D, Shi X, Wu X:Incidence of Postoperative Cognitive Dys- function (POCD) in Aged-patients After General Anesthesia. China Anesthesia and Analgesia 2004; 6: 164-166

    RESULT

MeSH Terms

Conditions

Cognition DisordersPostoperative Cognitive Complications

Interventions

Propofol

Condition Hierarchy (Ancestors)

Neurocognitive DisordersMental DisordersPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognitive Dysfunction

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Qulian Guo, PhD

    Xiangya Hospital, Central South University, Changsha, China

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2012

First Posted

October 17, 2012

Study Start

October 1, 2012

Primary Completion

January 1, 2014

Study Completion

June 1, 2014

Last Updated

May 31, 2013

Record last verified: 2012-10

Locations